Therapeutic schemes remain very similar for every patient, although, according to the 2021 WHO classification, gliomas split into three types: IDH1-mutated/1p/19q-codeleted oligodendroglioma, IDH1-mutated astrocytoma, or IDH1 wild-type glioblastoma [1]. The gene discussed is IDH1; the disease is central nervous system cancer.